- Home
- INR vs BSX Comparison
INR vs BSX Comparison
Compare INR & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INR
- BSX
- Stock Information
- Founded
- INR 2017
- BSX 1979
- Country
- INR United States
- BSX United States
- Employees
- INR N/A
- BSX N/A
- Industry
- INR
- BSX Medical/Dental Instruments
- Sector
- INR
- BSX Health Care
- Exchange
- INR NYSE
- BSX Nasdaq
- Market Cap
- INR 295.3M
- BSX 138.4B
- IPO Year
- INR 2025
- BSX 1992
- Fundamental
- Price
- INR $15.22
- BSX $101.69
- Analyst Decision
- INR Strong Buy
- BSX Strong Buy
- Analyst Count
- INR 7
- BSX 22
- Target Price
- INR $26.86
- BSX $112.86
- AVG Volume (30 Days)
- INR 413.0K
- BSX 7.7M
- Earning Date
- INR 08-11-2025
- BSX 07-23-2025
- Dividend Yield
- INR N/A
- BSX N/A
- EPS Growth
- INR N/A
- BSX 15.23
- EPS
- INR 1.89
- BSX 1.37
- Revenue
- INR $293,962,000.00
- BSX $17,554,000,000.00
- Revenue This Year
- INR $49.00
- BSX $17.50
- Revenue Next Year
- INR $16.39
- BSX $10.75
- P/E Ratio
- INR $8.17
- BSX $74.73
- Revenue Growth
- INR 62.18
- BSX 19.36
- 52 Week Low
- INR $13.64
- BSX $71.88
- 52 Week High
- INR $23.00
- BSX $107.53
- Technical
- Relative Strength Index (RSI)
- INR N/A
- BSX 44.28
- Support Level
- INR N/A
- BSX $101.56
- Resistance Level
- INR N/A
- BSX $104.70
- Average True Range (ATR)
- INR 0.00
- BSX 1.76
- MACD
- INR 0.00
- BSX -0.16
- Stochastic Oscillator
- INR 0.00
- BSX 12.78
About INR INFINITY NATURAL RESOURCES INC
Infinity Natural Resources Inc is an oil and natural gas exploration and production company. The group focused on developing unconventional reserves in Appalachia. The company is engaged in acquiring, exploring, producing, and developing properties for producing oil, natural gas, and natural gas liquids (NGLs) from underground reservoirs.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.